within Pharmacolibrary.Drugs.ATC.R;

model R03CC10
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg â†’ kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R03CC10</td></tr><td>route:</td><td></td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Carbuterol is a beta-2 adrenergic agonist that was investigated as a bronchodilator for the treatment of asthma and other obstructive airway diseases. It is a sympathomimetic agent structurally related to other beta-2 agonists like salbutamol. Currently, carbuterol is not an approved medication in most countries and is rarely used clinically.</p><h4>Pharmacokinetics</h4><p>No peer-reviewed pharmacokinetic studies or clinical publications reporting human PK parameters of carbuterol were found as of 2024. Parameters below are left blank or are estimates based on class information.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R03CC10;
